INTRODUCTION
Since 1975, it is recognized that multinucleated osteoclasts are cells that form from monocyte/macrophage-lineage cells [1] [2] [3] [4] . It appeared that osteoclasts could be derived from a number of cell types belonging to the myeloid differentiation pathway. Osteoclasts can be generated not only from bone marrow precursors [4] but also from blood-borne monocytes [5, 6] , splenocytes [2] , peritoneal macrophages [5] , and dendritic cells (DC) [7, 8] . In the context of bone remodeling, some of these sources of osteoclast precursors may not be physiological, as osteoclasts are formed in the proximity of the bone surface, in an environment relatively rich in hematopoietic stem cells. In this context, little is known about what cell type of myeloid differentiation is most primed for osteoclast differentiation. Attempts to characterize osteoclast precursor cells in bone marrow have used fractionation with markers CD11b and Gr-1/Ly-6G, which are also expressed on granulocytes [9] . CD11b may not be the ideal marker to isolate osteoclast precursors, as two studies showed that CD11bϩ and CD11b-cells are able to differentiate into osteoclasts [9, 10] .
To determine what cell type of the myeloid differentiation is prone to differentiate into osteoclasts, we fractionated mouse bone marrow into phenotypically defined, successive stages of myeloid development using CD31 (ER-MP12) and Ly-6C (ER-MP20) expression profiles [11, 12] . These fractions encompass early blasts (CD31 hi /Ly-6C -), myeloid blasts (CD31 ϩ /Ly-6C ϩ ), and monocytes (CD31 -/Ly-6C hi ) and have been shown to be the only fractions responsive to M-CSF [11] and GM-CSF [12] . Such stimulation leads to the development of macrophages and DC, respectively. Macrophage as well as DC maturation followsthe sequence of early blasts, myeloid blasts, monocytes, and subsequently, macrophages [11] or DC [12] , resulting in increased expression of macrophage markers CD11b/macrophage-antigen 1 and F4/80 [11] or DC markers MHC class II and CD11c [12] , respectively. In various studies, the present distinction of myeloid precursor stages based on CD31/Ly-6C expression was validated and used to investigate myeloid development under different experimental conditions [11] . Using these markers, bone marrow can be fractionated accurately, enabling the isolation of cell fractions relatively devoid of lymphocytic or granulocytic cells [11] , whereas such cell types were possible contaminants in studies where CD11 -/Gr-1 - [9] or CD11b -/lo /CD45R - [10] cells were studied as osteoclast precursors.
Here, we have investigated whether any of these defined, successive myeloid differentiation stages distinguish themselves as a primary source for osteoclast differentiation.
Immunofluorescence labeling, flow cytometry, and sorting
All immunofluorescent labelings and washes took place in PBS containing 1% BSA. Bone marrow cell suspensions were spun down (200 g, 10 min, 4°C) and incubated for 30 min in 25 l biotinylated ER-MP12, recognizing CD31 [11]/10 6 cells, which were washed once and incubated in 25 l/10 6 cells FACS buffer containing FITC-conjugated ER-MP20, recognizing Ly-6C [11] and streptavidin-PE conjugate (Becton Dickinson, San Jose, CA, USA; 10 l/10 6 cells) for 30 min. Cells were washed and recovered in culture medium. Cells were sieved through 50 m filters (filcons, Becton Dickinson) before cell sorting. Early blasts (CD31 hi /Ly-6C -), myeloid blasts (CD31 ϩ /Ly-6C ϩ ), and monocytes (CD31 -/Ly-6C hi ) were sorted at 3 ϫ 10 7 cells/h on FACSAria (Becton Dickinson). A typical profile is shown (see Fig. 1 ). Similar numbers of tartrate-resistant acid phosphatase (TRACP)-positive, multinucleated cells were found after a culture period of 6 days (unlabeled: 46Ϯ12; labeled and sorted: 50Ϯ13, obtained from 1.0ϫ10 5 bone marrow cells; meanϮSEM; nϭ6 mice), indicating that cell labeling and sorting did not affect osteoclastogenesis.
Osteoclastogenesis
Sorted cells were plated in 96-well flat-bottom tissue culture-treated plates (Costar, Cambridge, MA, USA) at a density of 1.5 ϫ 10 4 cells/well in 150 l culture medium containing 30 ng/ml recombinant murine (rm)M-CSF (R&D Systems, Minneapolis, MN, USA), with or without 20 ng/ml rm-receptor activator of NF-B ligand (RANKL; RANKL-TEC, R&D Systems). In other experiments, cells were seeded on 650 m thick bovine cortical bone slices. Culture media were replaced every 3 days. At the end of the culture period, wells were washed with PBS and fixed in 4% PBS-buffered formaldehyde and stored at 4°C (used for TRACP staining) or in water (used for bone resorption) or dissolved in RNA lysis buffer from the RNeasy Mini Kit (Qiagen, Hilden, Germany) and stored at -80ºC (for RNA isolation).
In some experiments, cells were cultured for 3 days in the presence of M-CSF and RANKL, detached with cell dissociation solution (Sigma-Aldrich, St. Louis, MO, USA), and subsequently, recultured at a density of 10 4 cells for another 24 h in the presence of the cytokines.
Bone resorption
Sorted cells (1.5ϫ10 4 ) were cultured on bone slices with M-CSF and RANKL. Bone resorption was assessed as described before [13] ; resorption pits were visualized by using Coomassie Brilliant blue. The surface areas of individual resorption pits were measured using Image-Pro Plus software (MediaCybernetics, Silver Spring, MD, USA).
RNA analysis and real-time quantitative PCR (qPCR)
RNA isolation and real-time qPCR were performed as described in detail [14] . Real-time PCR primers were designed using the Primer Express software, Version 2.0 (Applied Biosystems, Foster City, CA, USA; Table 1 ). To avoid amplification of genomic DNA, each amplicon spanned at least one intron. For the external standard curve used in the PCR reactions, cDNA was used from bone marrow, which was cultured for 4 days with M-CSF ϩ RANKL. The PCR reactions of the different amplicons had equal efficiencies.
PBGD was used as the housekeeping gene [15] . Expression of this gene was not affected by the experimental conditions. Samples were normalized for the expression of PBGD by calculating the ⌬ comparative threshold (Ct; Ct PBGDCt gene of interest ), and expression of the different genes is expressed as 2 Ϫ(⌬Ct) .
CFU assay
To determine the number of cells per fraction that proliferated in the presence of M-CSF or M-CSF ϩ RANKL, 2 ϫ 10 4 total bone marrow cells or 10 3 early blasts, myeloid blasts, or monocytes were seeded in 1 ml 1% methocult medium (M3134, Stem Cell Technologies, Vancouver, Canada), supplemented with 60 ng/ml M-CSF and 40 ng/ml RANKL [13] . The number of colonies (Ͼ10 cells/colony) was assessed after 8, 11, and 14 days of culturing. Size of colonies was measured at 11 days using a computerized XY tablet and Image-Pro Plus software (MediaCybernetics). At the end of the culture period, methocult was washed gently for several times with water, upon which a TRACP staining was performed. Colonies were scored as TRACP-negative or as colonies containing TRACP-positive cells. 
H]Thymidine labeling
To determine the effect of M-CSF or the combination of M-CSF ϩ RANKL on proliferation at the time-point where multinucleation was first observed, unfractionated bone marrow cells, early blasts, myeloid blasts, and monocytes were cultured in the presence of 30 ng/ml M-CSF or 30 ng/ml M-CSF ϩ 20 ng/ml RANKL, and after 3 days, [ 3 H]thymidine (7.4 MBq/well, Amersham Biosciences, Uppsala, Sweden) was added to the culture for 24 h. Excess label was washed away, and incorporation was measured.
Statistical analysis
Bone marrow cell sorts were from three mice per experiment. All data shown were from two pooled experiments (nϭ6). The Kruskal-Wallis nonparametric variance test (one-way ANOVA) followed by Tukey-Kramer's multiple comparison test was used when multiple comparisons were made. Differences between groups were considered significant at P Ͻ 0.05 (two-tailed).
RESULTS

Earliest osteoclast formation from myeloid blasts
Based on the CD31 and Ly-6C antigen expression, six bone marrow fractions ( to originate from Fractions 1 (enriched in early blasts), 4 (enriched in myeloid blasts), and 6 (enriched in monocytes).
Formation of osteoclast-like cells proved to be cell densitydependent (Fig. 2B) . Cells ( 15ϫ10 3 )/fraction/well as seeding density were used throughout the remaining analyses. To investigate putative differences in kinetics of osteoclast formation potential between the various fractions, M-CSF/RANKLstimulated cultures were analyzed at different time-points ( Fig.  2) . At 2 days of culture, all cells deriving from early blasts were TRACP-negative, whereas TRACP-positive, mononuclear cells were detectable primarily in myeloid blast cultures and to a lesser extent, in monocyte cultures. No osteoclast-like cells could be detected during the first 3 days in any of the cultures. However, highest numbers of osteoclast-like cells were formed already at Day 4 from myeloid blasts (Fig. 2 , A, C, and F). At least three times more osteoclast-like cells were formed from this fraction compared with the other fractions (PϽ0.001 myeloid blast vs. bone marrow or early blasts or monocytes, Fig.  2C ). Formation of TRACP-positive, multinucleated cells from myeloid blasts peaked at 4 days (Fig. 2F ), followed by a smaller peak at 8 days. This secondary peak is possibly a result of fusion of myeloid blast progeny with smaller multinucleated cells (three to five nuclei), as particularly this latter category dropped between 4 and 8 days (106Ϯ17 vs. 37Ϯ5; Pϭ0.0004; nϭ6; meanϮSD). As a result, larger osteoclast-like cells (greater than five nuclei) appeared at the expense of smaller osteoclasts at Day 8. For the other fractions, the highest numbers of osteoclast-like cells were present at Day 8 in total bone marrow ( Fig. 2D ), early blast (Fig. 2E) , and monocyte cultures (Fig. 2G) . Extraordinary large, multinucleated cells with a diameter of almost 1 mm and containing many nuclei arose after prolonged culture (10 days) of myeloid blasts and monocytes but not in early blast cultures ( Fig. 2A , lower panel).
Differences in proliferation among the three myeloid stages could account for the observed differences in osteoclast formation. To study whether M-CSF ϩ RANKL-responsive cells from the three fractions are prone to fuse and to correct for differences in proliferation, cells were collected prior to the onset of cell fusion at 3 days of culture and were replated at identical densities (10 4 cells). Cells were cultured further for 24 h. Multinucleated, TRACP-positive cells were only observed in myeloid blast and monocyte cultures (Fig. 2 , H and I) with 2.5ϫ more multinucleated cells in myeloid blast cultures (Fig. 2H ). Larger multinucleated cells containing greater than five nuclei were seen exclusively in myeloid blast cultures (Fig. 2I) .
Osteoclast formation on cortical bone slices took longer than on plastic. First evidence for the presence of osteoclast-like cells was seen after 6 days of culture (Fig. 3, A and B-F) . Again, at early time-points, more osteoclast-like cells were formed from myeloid blasts than from any other cell fraction. At Day 6, at least three times more osteoclast-like cells were formed from myeloid blasts compared with total bone marrow or early blasts (PϽ0.001) or monocytes (PϽ0.01). In cultures of unfractionated bone marrow (Fig. 3C) , the highest number of osteoclasts was present at Day 8 and for monocytes, at Days 6 -8 (Fig. 3F) . Between Days 8 and 10, significantly more osteoclast-like cells were present in cultures from early blasts than at earlier time-points (Fig. 3D) . No extraordinary large multinucleated cells were seen when cultured for a prolonged time on bone (Fig. 3A, lower panel) .
Earlier and more bone resorption from myeloid blast-derived osteoclasts Osteoclastic activity was assessed by analyzing bone resorption after 6, 8, and 10 days of culturing. At 6 days of culture, resorption pits were present in bone slices, on which myeloid blasts or monocytes were cultured (Fig. 3A, upper panel) . First signs of osteoclastic activity from early blast-derived osteoclasts were observed after 8 days (Fig. 4, A, middle panel, B , and C), in agreement with the immature nature of the progenitor cells. Initial differences between early blast-derived osteoclasts and myeloid blast-or monocyte-derived osteoclasts in percentage of bone resorption and pit size disappeared over time (Fig. 4A, bottom panel, B, and C) . However, at Days 6 and 8, the percentage of resorbed bone (PϽ0.01) was significantly higher for the myeloid blast fraction compared with any other fraction.
Pit size of myeloid-derived and monocyte-derived osteoclasts was significantly larger (PϽ0.05, Fig. 4C ) than pit size from early blast-derived osteoclasts.
Distinct expression pattern of osteoclast-related genes per myeloid precursor cell type 
Osteoclast gene expression over time
We analyzed the expression of osteoclastogenesis-related genes c-Fms and RANK (Fig. 5, A and B) , osteoclast-related genes NFATc1, DC-STAMP, TRACP, calcitonin receptor (Fig.  5, C-F) , ␤3 integrin subunit (Supplemental Fig. 1A) , and cathepsin K (Supplemental Fig. 1B ) over time for all myeloidlineage fractions upon stimulation with M-CSF and RANKL. In general, these cultures resulted in a time-dependent, increased expression of osteoclast-related genes (Fig. 5, C-F) for all cell fractions. Except for monocyte marker F4/80 and the ␤5 integrin unit, expression of which is reciprocally regulated with the ␤3 integrin during osteoclast maturation [16, 17] , all osteoclastogenesis (RANK and c-Fms, Fig. 4, A and B) and osteoclastrelated genes (Fig. 5, D-F) were up-regulated, and highest expression was reached at t ϭ 4 days for DC-STAMP, TRACP, and calcitonin receptor (Fig. 5, D-F) . Expression decreased after an initial rise (NFATc1, Fig. 4C ) at t ϭ 3 (myeloid blasts) or t ϭ 4 days (bone marrow, early blasts, and monocytes).
For monocytes, myeloid blasts, and bone marrow, an initial increase of expression of the typical monocyte-lineage marker F4/80 (Fig. 5G) and the ␤5 integrin unit (Fig. 5H ) was noted after 1 day of culture with M-CSF and RANKL. This was followed by a decrease of expression at Days 2-4. Peak expression of these mRNAs in early blast-derived cells was only Pit size over time. After 8 days, the pit size of myeloid blast-and monocyte-derived osteoclasts was larger than pit size from osteoclasts derived from early blasts and total bone marrow. Percentage bone resorbed and pit size (meanϮSEM) are from two experiments; n ϭ 3 per experiment; *, P Ͻ 0.05. after 6 days of culture (Fig. 5, G and H) . The latter finding appears to coincide with the lower degree of differentiation of this fraction of cells.
Expression of osteoclast-related genes per cell fraction
Unfractionated bone marrow and each of the three cell fractions displayed a characteristic expression pattern of osteoclast-related genes during culture, correlating with the kinetics of osteoclast development from the various fractions. Expression was strikingly similar among the osteoclast-related genes TRACP, calcitonin receptor, ␤3 integrin, and cathepsin K (Fig. 5, C-F; Supplemental Fig. 1, A and B) .
Myeloid blast fraction contains highest number of colony-forming cells
Enhanced osteoclast formation by the myeloid blast cell fraction could mean that this fraction contains more proliferating cells or cells that proliferate faster. We investigated this possibility by studying the colony-forming capacity of the various fractions in a viscous methylcellulose-containing medium supplemented with M-CSF or the combination of M-CSF and RANKL [13, 18] . In principle, the number of colonies reflects the number of cells that proliferate under the influence of the growth factors, and the size of the colonies possibly reflects proliferation rate per osteoclast precursor cell.
Examples of colonies are shown in Figure 6A . No colonies grew in the absence of M-CSF. Similar numbers of colonies were found between M-CSF and M-CSF ϩ RANKL for the different bone marrow cell fractions studied. Significantly more colonies were obtained from the myeloid blast fraction compared with early blasts and monocytes (Fig. 6B) .
In general, colonies emerged from 6 days onward and were compact and had a more or less round shape. However, colonies formed from early blasts (in the presence of M-CSF and RANKL) were densely packed in the center of the colony, whereas the cells at the periphery migrated away from the center (Fig. 6A, lower panel) . Consequently, colony size was increased significantly in early blasts under these conditions (Fig. 6C) . Average colony size obtained from the other three cell fractions was similar in M-CSF-and M-CSF ϩ RANKL-stimulated cultures, although the average size of colonies differed considerably; for instance, myeloid blastderived colonies were 2.5 times larger than monocyte-derived colonies (Fig. 6A) . Statistical analyses revealed no significant differences in colony size. We assessed the responsiveness to RANKL in the M-CSF ϩ RANKL-cultured colonies by analyzing the extent of TRACP-positive colonies. At 8 days, there were more colonies containing TRACP-positive cells derived from early blast and myeloid blasts than from monocytes (Fig. 6, E and F) . Percentages of colonies containing TRACP-positive cells leveled at 11 days at ϳ60% for unfractionated bone marrow and all fractions.
Divergent effects of M-CSF versus M-CSF ϩ RANKL on [ 3 H]thymidine incorporation
As similar numbers of colonies were obtained with M-CSF or M-CSF ϩ RANKL, we studied the effect of these two culture conditions on proliferation of the different cell fractions between 3 and 4 days of culturing in adherent plates. This is the time-frame crucial for the initial formation of multinucleated cells on plastic, as no multinucleated cells were seen at Day 3, whereas at Day 4, the first multinucleated cells are formed. Hardly any proliferation took place in the absence of cytokines. No differences in proliferation were found between M-CSF-and M-CSF ϩ RANKL-treated, unfractionated bone marrow and early blasts. However, proliferation was significantly lower in myeloid blast and monocyte cultures stimulated with M-CSF ϩ RANKL compared with M-CSF alone (Fig. 6G) . Thus, at the onset of cell fusion, RANKL affects mainly proliferation of osteoclast precursor cells in the latter two cell fractions and not in early blast and total bone marrow cultures.
DISCUSSION
Multinucleated osteoclasts are formed in close proximity to the bone surface. Immature cells from bone marrow, also containing osteoclast progenitor cells, are in close vicinity to cells of the osteoblast lineage. In the present study, we demonstrate that murine osteoclasts are formed exclusively from bone marrow populations that contain cells of the myeloid lineage: from early blasts, myeloid blasts, and monocytes. Following stimulation with M-CSF and RANKL, each of these cell types followed its own distinctive route of osteoclast formation (summarized in Fig. 7) . Particularly, one cell population from the myeloid differentiation route, the myeloid blasts, proved to form osteoclasts within a relatively short period of time. The fractionation of the different bone marrow cell populations was done by making use of CD31 and Ly-6C. These markers were used previously to monitor the differentiation of macrophages [11] and DC [12] . In both studies, it was shown that early blasts have the highest proliferative potential but require more time to differentiate than more mature stages. These studies further showed that differentiation of macrophages and DC follows the consecutive differentiation route: early blast, myeloid blast, monocyte, and eventually, macrophage [11] or DC [12] . A major source of osteoclast precursors is considered to be blood monocytes [5, 19] . Conceivably, the blood-borne monocyte seems to be the recruited cell type for osteoclast formation at sites devoid of bone marrow, such as at eroding joints in rheumatoid arthritis. However, two recent reports support the concept that osteoclast development may deviate from the alleged mainstream of mature monocyte/ macrophage development. Jacquin et al. [10] have shown that mouse bone marrow-derived osteoclasts form with highest efficiency from CD11b
-/low cells, and monocytes typically have a CD11b hi phenotype. Clanchy et al. [20] have shown that human blood-derived osteoclasts form with high frequencies from proliferating, immature monocytes. Multinucleated giant cells also form at higher frequencies from fresh monocytes than from monocytes differentiated for some days toward macrophages [21] . Although osteoclasts can be generated from all three stages of myeloid differentiation in mouse bone marrow, our study revealed that myeloid blasts rather than monocytes are the candidate cells from which osteoclasts are readily formed. Hence, preferred osteoclast formation seems to deviate from the classical maturation sequence early blasts 3 myeloid blasts 3 monocytes and ultimately, mature end-stage. If this sequence were apparent first, osteoclasts would have been detected from monocytes. Therefore, our results suggest that osteoclast differentiation in the bone marrow follows a sequence different from macrophage or DC differentiation: Osteoclasts are preferentially formed from a less-mature stage, being the myeloid blasts. Compared with monocytes, this stage contains more M-CSF ϩ RANKL-responding cells, as detected with the CFU assay. However, in an attempt to minimize the effect of proliferation, we assessed osteoclast formation by replating M-CSF-and RANKL-responsive cells from all cell types at 3 days, 1 day before fusion occurs. Also in this experiment, myeloid blasts gave rise to more multinucleated cells than early blasts and monocytes.
qPCR analysis further revealed that expression of NFATc1, an important transcription factor for osteoclast-related genes [22] , precedes expression of osteoclast-related genes in myeloid blast-derived cells and peaks at 3 days of culturing with M-CSF and RANKL, 1 day earlier than observed in the other cell fractions (Fig. 5) . In parallel with the drop in osteoclast numbers after Day 4, mRNA expression of osteoclast-related genes TRACP, calcitonin receptor, and cathepsin K is highest at Day 4 and typically drops in the myeloid blast-derived cultures, whereas expression of these genes peaks later in case of early blast-derived osteoclasts or reaches a plateau phase in case of monocyte-derived osteoclasts.
In line with the immature nature of the precursor cells, osteoclast differentiation from early blasts took longer than differentiation from monocytes (Fig. 3, D and F) , resulting in a delay in osteoclastic activity (Fig. 4, B and C) and expression of osteoclast-related genes (Fig. 5) . Proliferation of early blasts was not inhibited by addition of RANKL, compared with M-CSF alone, whereas myeloid blast and monocyte proliferation were decreased under these conditions between 3 and 4 days of culturing (Fig. 6D) , possibly indicating that the M-CSF ϩ RANKL-cultured early blasts were not ready yet to differentiate into osteoclasts at that time-point. Myeloid blasts and monocytes with decreased proliferation when cultured with M-CSF and RANKL may have acquired the state of the relatively quiescent ostoclast precursor [23] . Especially cyclines, which are pivotal for proliferating cells, were shown to be down-regulated by RANKL in cultures at the time-point where the formation of syncytiae is about to start [23] . The intriguing wavered colony appearance generated in the presence of M-CSF and RANKL, as noted previously by Arai et al. [24] (Fig.  6A) , was only observed in early blast-derived colonies. This is another indication that early blasts respond differently to M-CSF and RANKL and implies that cells derived from these early blasts have the unique capacity to migrate within the viscous solution, possibly by expressing the appropriate adhesion molecules.
We showed that each of the three developmental stages of the myeloid lineage has its own characteristic osteoclast differentiation pathway. This suggests that the organism is flexible with regard to use of different cell types for osteoclast recruitment, as suggested recently by Rivollier et al. [7] . Their study showed that osteoclasts can also form from immature stages of DC, the cells closest to macrophages in hematopoietic development [7] . Recently, it was shown that distinct subsets of blood-borne monocytes exist, where fates were shown in rapid responses such as in inflammatory reactions or in slower reactions by contributing to the pool of resident macrophages in noninflamed tissues [25, 27] . Analogous to this dichotomy of monocytes in the circulation, different paces of osteoclast recruitment within the bone marrow cavity could be envisaged (see also Fig. 7) . In this respect, myeloid blasts could be the fast responders and early blasts and monocytes the reserve pool of osteoclast precursors. It is also feasible that the monocyte has acquired features of the F4/80-positive osteal tissue macrophage (OsteoMac), which possibly has a role related to anabolic functions, supporting bone formation by osteoblasts. Thus, the role of OsteoMacs and possibly monocytes as osteoclast precursor may be rather limited [26, 28] .
Heterogeneity of macrophages has long been recognized. Different microenvironments can give rise to macrophage diversity (reviewed in refs. [29, 30] ). In previous studies, we were the first to show that osteoclasts are also functionally distinct at different skeletal sites: Calvarial osteoclasts use different proteases and express higher levels of TRACP than long bone osteoclasts [31, 32] . Such heterogeneity among osteoclasts might be explained by existence of various precursor cells giving rise to different types of osteoclasts. More complex possibilities of the formation of osteoclasts can be proposed by assuming heterogenic fusions of diverse progenitors (e.g., early blasts and monocytes), a principle shown to exist in vivo for heterogeneous tumor/osteoclast precursor syncitiae [33] . In principle, heterogeneous fusion of the various precursors from the classical monocyte-lineage pathway alone or together with the recently discovered precursors from the DC-derived osteoclast pathway [34, 35] could give rise to a great diversity of osteoclasts, each of them equipped for the appropriate function at a desired skeletal site.
